SPHK1 and neoplasm: Consistent with previous findings in mouse models, the knockdown of SPHK1/MMP1 significantly reduced tumor growth (Figure 6O-Q), increased intratumoral PD-L1+ cell density, and inhibited CD8+ T cell exhaustion (Figure 6R-T).